PROVIDER PROFILE · NPI 1295794014

Luis AmbertMD

UrologyGuaynabo, PRI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

129

Unique beneficiaries

—

Total services

194

Distinct HCPCS

Medicare payment

$13K

Peer benchmark

Total Medicare services vs. 81 Urology providers in PR — top quintile (cohort median 119).

PRESCRIBING · PART D · 2024

Total Rx claims

7,968

Beneficiaries

—

Total drug cost

$405K

Distinct drugs

Brand share

29.9%

Top prescribed drugs

Tamsulosin Hcl1,878 claims

Bethanechol Chloride1,725 claims

Oxybutynin Chloride927 claims

Ciprofloxacin Hcl763 claims

Alfuzosin Hcl458 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$25K

Payment records

By payment type

Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$24K

Food and Beverage$584

FACILITY AFFILIATIONS

Hospital & Facility Affiliations (1)

CCN 400106

Hospital

REFERRAL NETWORK

Where Luis Ambert's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 1 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
METROHEALTH, INC.	23	63
Laboratorio Clinico Borinquen, Inc Clinical Laboratory · Caguas, PR	16	50
Laboratorio Clinico Bairoa Inc Clinical Laboratory · Caguas, PR	11	39

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
METROHEALTH, INC.	17	29

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history